Eton Pharmaceuticals ETON Cash Flow Statement (2017-2026)

NASDAQ ETON
$58.83 -0.51 (-0.87%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Eton Pharmaceuticals Quarterly Cash Flow Statement

Periods 34 quarters
Latest Jun 2026

Eton Pharmaceuticals cash flow statement data for the quarter ended Jun 2026. This cash flow statement covers 34 quarters of results from Dec 2017 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow Statement Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Jun2026
Operating Activities
Net Income
-2.02M-6.09M1.04M-5.33M-1.56M-3.04M2.81M-2.66M4.56M-0.58M-2.26M-0.81M-3.04M0.63M-1.40M-1.57M-2.58M-1.93M2.48M11.58M
Share-based CompensationStock Comp.
3.58M3.57M0.86M4.59M4.48M4.34M0.89M4.99M4.88M4.81M0.75M6.28M6.41M6.08M0.78M7.55M8.51M5.97M1.12M7.98M
Gains from Investment SecuritiesGains Investment
Cash from OperationsCash from Ops.
-0.37M-2.95M-5.12M1.22M2.46M-1.70M2.84M-1.55M7.10M0.87M0.39M-2.47M1.25M2.95M-0.77M2.09M7.96M12.03M-11.55M
Depreciation, Depletion & Amortization
Amortizatization of IntangiblesAmort. of Intangibles
0.04M0.04M0.04M0.04M0.03M0.09M0.03M0.03M0.03M0.03M0.03M0.03M0.02M0.03M1.04M0.29M0.05M0.19M0.17M
Depreciation & Amortization (CF)Dep. & Amort.
0.09M0.09M0.14M0.18M1.17M0.17M0.25M0.21M0.17M0.19M0.33M0.23M0.28M0.28M0.35M1.01M1.00M1.01M1.02M
Change in Working Capital
Change in ReceivablesChange Receivables
0.00M0.08M5.09M-4.67M0.04M0.66M0.35M1.02M0.21M0.41M-0.08M0.83M0.63M0.72M0.94M11.04M-1.95M-1.37M-1.32M
Change in InventoryChange Inventory
0.22M-0.04M0.02M-0.05M0.08M-0.12M0.38M0.23M-0.12M1.41M-0.25M-0.13M0.81M-0.47M11.49M-5.72M0.58M
Change in Account PayablesChange Payables
-0.24M1.52M-1.27M-0.39M-0.08M-0.24M0.71M-0.53M1.07M-0.59M0.10M0.41M-0.13M0.55M1.48M0.70M7.26M2.12M-3.28M
Change in Accured ExpensesChange Accured Exp.
0.11M0.37M0.12M-0.03M0.79M0.75M-0.06M1.24M0.81M-0.94M1.37M-1.64M0.51M0.57M2.04M-1.37M0.17M1.79M0.43M
Investing Activities
Capital ExpendituresCapex
0.00M0.00M0.01M0.01M0.01M0.01M0.01M0.28M0.05M
Cash from Investing ActivitiesCash from Investing
-0.00M-3.25M-0.01M-0.76M-2.00M-0.01M-0.78M-1.88M-38.13M-0.28M-0.05M
Financing Activities
Other financing activitiesOther financing
0.36M0.01M0.07M0.12M0.04M0.02M0.13M0.14M0.02M-0.06M0.01M0.17M6.82M0.39M0.20M
Cash from Financing ActivitiesCash from Financing
0.36M-0.14M0.07M-0.39M0.12M0.04M0.10M-0.05M-0.24M-0.37M-0.29M-0.38M-0.22M-0.39M33.57M0.39M0.42M
Change in Capital Stock
Net Shares Issued and RepurchasedNet Shares Issued
1.02M1.12M1.05M1.11M1.44M1.62M0.45M0.47M
Net Equity Issued and RepurchasedNet Equity Issued
Additional items
Change in Cash
0.69M-3.09M-8.30M0.82M1.82M-3.67M2.93M-1.60M6.86M0.50M-0.68M-4.73M1.04M2.57M-5.33M2.48M7.96M11.74M-11.18M
Free Cash FlowFCF
-0.37M-2.95M-5.12M1.21M2.45M-1.70M2.83M-1.55M7.10M0.87M0.39M-2.49M1.25M2.95M-0.78M2.09M7.96M11.74M-11.60M
Net Cash FlowNCF
-0.01M-3.09M-8.30M0.82M1.82M-3.67M2.93M-1.60M6.86M0.50M-0.68M-4.73M1.04M2.57M-5.33M2.48M7.96M11.74M-11.18M